AbCellera Biologics (ABCL) Exchange Rate Effect (2021 - 2026)
AbCellera Biologics' (ABCL) quarterly Exchange Rate Effect came in at -$38000.0 in Q1 2026, down 106.44% YoY from $590000.0 in Q1 2025, and down 113.1% on a QoQ basis from $290000.0 in Q4 2025.
AbCellera Biologics (ABCL) Exchange Rate Effect (2021 - 2026) Analysis & Trends
AbCellera Biologics (ABCL) has 6 years of Exchange Rate Effect data on file, last reported at -$38000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 106.44% year-over-year to -$38000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $469000.0 (up 137.64% YoY) and the FY2025 annual result came in at $1.1 million, up 141.92% from the prior year.
- Exchange Rate Effect declined to -$38000.0 in Q1 2026, from $290000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.1 million in Q4 2023 to a low of -$8.6 million in Q3 2022.
- A 5-year average of -$621647.1 and a median of -$43000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 3841.01% — and 2025, when it surged 1869.77%.
- Tracing ABCL's Exchange Rate Effect over 5 years: stood at $364000.0 in 2022, then surged by 193.41% to $1.1 million in 2023, then tumbled by 302.25% to -$2.2 million in 2024, then jumped by 113.43% to $290000.0 in 2025, then slumped by 113.1% to -$38000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$38000.0 (Q1 2026), $290000.0 (Q4 2025), and -$544000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | -430,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -430,000.00 |
| Jun 30, 2026 | -430,000.00 |
| Mar 31, 2026 | -38,000.00 |
| Mar 31, 2026 | -38,000.00 |
| Dec 31, 2025 | 290,000.00 |
| Dec 31, 2025 | 290,000.00 |
| Sep 30, 2025 | -544,000.00 |
| Sep 30, 2025 | -544,000.00 |
| Jun 30, 2025 | 761,000.00 |
| Jun 30, 2025 | 761,000.00 |
| Mar 31, 2025 | 590,000.00 |
| Mar 31, 2025 | 590,000.00 |
| Dec 31, 2024 | -2.16 Mn |
| Dec 31, 2024 | -2.16 Mn |
| Sep 30, 2024 | 367,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Mar 31, 2024 | -781,000.00 |
| Mar 31, 2024 | -781,000.00 |